Technical Analysis for ELVN - Enliven Therapeutics, Inc.

Grade Last Price % Change Price Change
D 18.63 5.79% 1.02
ELVN closed up 5.79 percent on Wednesday, March 27, 2024, on 60 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.79%
Calm After Storm Range Contraction 5.79%
NR7 Range Contraction 5.79%
Inside Day Range Contraction 5.79%
Wide Bands Range Expansion 5.79%
Overbought Stochastic Strength 5.79%
Stochastic Sell Signal Bearish 4.78%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.78%

   Recent Intraday Alerts

Alert Time
Non-ADX 1,2,3,4 Pullback Entry about 14 hours ago
Rose Above Previous Day's High about 14 hours ago
Up 5% about 14 hours ago
Possible NR7 about 16 hours ago
Possible Inside Day about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Protein Kinase Inhibitor Tyrosine Kinase Receptors Her2 Chronic Myeloid Leukemia

Is ELVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.98
52 Week Low 9.84
Average Volume 139,207
200-Day Moving Average 15.19
50-Day Moving Average 15.72
20-Day Moving Average 15.65
10-Day Moving Average 16.35
Average True Range 1.65
RSI (14) 61.09
ADX 23.86
+DI 25.84
-DI 16.56
Chandelier Exit (Long, 3 ATRs) 14.56
Chandelier Exit (Short, 3 ATRs) 15.84
Upper Bollinger Bands 20.43
Lower Bollinger Band 10.87
Percent B (%b) 0.81
BandWidth 61.12
MACD Line 0.70
MACD Signal Line 0.22
MACD Histogram 0.4718
Fundamentals Value
Market Cap 767.78 Million
Num Shares 41.2 Million
EPS -0.92
Price-to-Earnings (P/E) Ratio -20.25
Price-to-Sales 0.00
Price-to-Book 2.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.59
Resistance 3 (R3) 20.44 19.62 20.27
Resistance 2 (R2) 19.62 19.12 19.70 20.16
Resistance 1 (R1) 19.13 18.81 19.37 19.28 20.05
Pivot Point 18.31 18.31 18.44 18.39 18.31
Support 1 (S1) 17.82 17.81 18.07 17.98 17.21
Support 2 (S2) 17.00 17.50 17.08 17.10
Support 3 (S3) 16.51 17.00 16.99
Support 4 (S4) 16.67